Quote:
Originally Posted by Fish
Oxford, AstraZeneca Coronavirus Vaccine Produces Immune Response in Adults
In an update this Monday, the University of Oxford and British drugmaker AstraZeneca announced that their experimental COVID-19 vaccine produces a similar immune response in both older and younger adults.
The current University of Oxford vaccine, also known as, AZD1222, is considered a frontrunner in the race to protect people around the world from the virus. The news today gives us a glimmer of hope as many countries around the world deal with a new wave of COVID-19.
“It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the COVID-19 disease severity is higher,” says a representative from AstraZeneca in an article for Reuters.
“The results further build the body of evidence for the safety and immunogenicity of AZD1222."
|
Good news. Now let's see that phase 3 data.
(Even a sneak peak would be nice)